|
Enamine Ltd
crif1 41 Crif1 41, supplied by Enamine Ltd, used in various techniques. Bioz Stars score: 93/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more https://www.bioz.com/product/tmp-195/TMP-%E2%80%8B195/pm39936374-91-27-57 Average 93 stars, based on 1 article reviews
crif1 41 - by Bioz Stars,
2026-10
93/100 stars
|
Buy from Supplier |
|
MedChemExpress
tmp195 ![]() Tmp195, supplied by MedChemExpress, used in various techniques. Bioz Stars score: 94/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more https://www.bioz.com/product/tmp-195/TMP195/pmc13285577-412-29-34 Average 94 stars, based on 1 article reviews
tmp195 - by Bioz Stars,
2026-10
94/100 stars
|
Buy from Supplier |
|
Selleck Chemicals
tmp159 ![]() Tmp159, supplied by Selleck Chemicals, used in various techniques. Bioz Stars score: 93/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more https://www.bioz.com/product/tmp-195/TMP195/bio_rxiv__2025__08__01__668069-41-25-26 Average 93 stars, based on 1 article reviews
tmp159 - by Bioz Stars,
2026-10
93/100 stars
|
Buy from Supplier |
|
Axon Medchem LLC
tmp 195 ![]() Tmp 195, supplied by Axon Medchem LLC, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more https://www.bioz.com/product/tmp-195/tmp195/pmc05842265-49-0-5 Average 90 stars, based on 1 article reviews
tmp 195 - by Bioz Stars,
2026-10
90/100 stars
|
Buy from Supplier |
|
BioMimetic Therapeutics
hdac inhibitor tmp-195 ![]() Hdac Inhibitor Tmp 195, supplied by BioMimetic Therapeutics, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more https://www.bioz.com/product/tmp-195/nanoparticles+carrying+the+tam+repolarizer+tmp195/pmc09677115-132-12-8 Average 90 stars, based on 1 article reviews
hdac inhibitor tmp-195 - by Bioz Stars,
2026-10
90/100 stars
|
Buy from Supplier |
|
MedKoo Inc
tmp195 ![]() Tmp195, supplied by MedKoo Inc, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more https://www.bioz.com/product/tmp-195/tmp195/pmc07528251-142-2-5 Average 90 stars, based on 1 article reviews
tmp195 - by Bioz Stars,
2026-10
90/100 stars
|
Buy from Supplier |
|
CELLAGEN TECHNOLOGY LLC
tmp195 ![]() Tmp195, supplied by CELLAGEN TECHNOLOGY LLC, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more https://www.bioz.com/product/tmp-195/tmp195/pm31732526-79-61-62 Average 90 stars, based on 1 article reviews
tmp195 - by Bioz Stars,
2026-10
90/100 stars
|
Buy from Supplier |
|
TMP195 is a selective class IIa histone deacetylase (HDAC) inhibitor (IC50s= 59 nM, 60 nM, 26 nM and 15 nM for HDAC4, HDAC5, HDAC7 and HDAC9 respectively), and is >100 fold selective over other HDACs
|
Buy from Supplier |
|
InformationTMP195 TMP195 (TFMO 2) is a selective, first-in-class, class IIa HDAC inhibitor with IC50 of 300 nM in cell-based class IIa HDAC assays.In vitroTMP195 has low potency in recombinant class I and IIb HDAC assays,
|
Buy from Supplier |
|
TMP195(Cat No.:I013525)is a selective class IIa histone deacetylase (HDAC) inhibitor known for modulating macrophage phenotype and inflammatory responses. By targeting HDAC4, HDAC5, HDAC7, and HDAC9, TMP195 promotes a shift toward pro-resolving, phagocytic macrophages, enhancing the
|
Buy from Supplier |
Image Search Results
Journal: Autophagy
Article Title: Trophoblast aging driven by IL33 deficiency elevates recurrent pregnancy loss risk through SNAP29 lactylation-mediated autophagy impairment
doi: 10.1080/15548627.2026.2659946
Figure Lengend Snippet: Senescence-induced glycolysis and lactate accumulation impair autophagy in trophoblasts. ( A ) Heatmap showed the relative expression changes of seven proteins in the glycolysis/gluconeogenesis pathway. ( B ) Glucose and lactate concentrations in the supernatant of senescent HTR-8/SVneo cells treated with or without IL33 (10 ng/mL). ( C and D ) Western blot for SQSTM1 or LC3B-II:I in normal and senescent HTR-8/SVneo cells treated with different concentration of lactate (0, 10, 20 mM for 48 h). Relative expression levels of proteins were standardized using internal reference ACTB. ( E ) The expression of lactylation level was analyzed by immunohistochemistry staining in normal and URPL villi ( n = 6 per group). Scale bar: 200 μm. ( F ) The expression of lactylation level was analyzed by immunohistochemistry staining in wt and il33 −/− mice ( n = 6 per group). Scale bar: 500 μm. ( G ) Western blot for lactylation level in HTR-8/SVneo cell senescence models treated with or without IL33 (10 ng/mL). Relative expression levels of proteins were standardized using internal reference histone H3. ( H ) Western blot for lactylation level in normal and senescent HTR-8/SVneo cells treated with different concentration of lactate (0, 10, 20 mM for 48 h). Relative expression levels of proteins were standardized using internal reference histone H3. ( I ) Western blot for lactylation and acetylation level in trophoblast cells treated with tacedinaline (5 μM, 48 h) or TMP195 (5 μM, 48 h). Relative expression levels of proteins were standardized using internal reference histone H3. ( J ) The expression of SQSTM1 was detected by immunofluorescence in HTR-8/SVneo cells treated with tacedinaline (5 μM, 48 h) or TMP195 (5 μM, 48 h). Scale bar: 10 μm. ( K and L ) The level of autophagy was detected by the DAL/DAP fluorescence probes in HTR-8/SVneo cells treated with tacedinaline (5 μM, 48 h) or TMP195 (5 μM, 48 h). Scale bar: 50 μm. Immunofluorescence staining results was quantified with average intensity. All data were generated using ImageJ. Statistical data were presented as mean ± SEM. *p < 0.05, **p < 0.01, ***p < 0.001, ns, no significant difference , using two-tailed Student’s t-test (e, F) and one-way ANOVA test (b, d, L).
Article Snippet: IL33 (10 ng/mL; PeproTech, 200–33), rapamycin (2 μM, 24 h; Sigma-Aldrich, V900930), lactate (10 or 20 mM, 48 h; Sigma-Aldrich, L6661), tacedinaline (5 μM, 48 h; MedChem Express, HY-50934),
Techniques: Expressing, Western Blot, Concentration Assay, Immunohistochemistry, Staining, Immunofluorescence, Fluorescence, Generated, Two Tailed Test
Journal: Biological Research
Article Title: Inhibition of phospholipase D2 augments histone deacetylase inhibitor-induced cell death in breast cancer cells
doi: 10.1186/s40659-020-00294-3
Figure Lengend Snippet: PLD2 inhibition sensitizes SAHA-induced apoptotic cell death. a MDA-MB-231 cells were transfected with siRNA of PLD2 and then treated with vehicle or SAHA (5 μM) for 36 h. Apoptosis was examined via flow cytometry and presented as the percentage of cells labeled with annexin V-PE. b MDA-MB-231 cells were stained with propidium iodide (1 μg/mL) and the population of subG1 apoptotic cells was determined using FACScan flow cytometry. c MDA-MB231 cells were treated with T247 (3 μM), TMP195 (3 μM), and PLD2 inhibitor (10 μM) for 36 h, and caspase-3 activity was examined. d MDA-MB231 were treated with SAHA (5 μM), rapamycin (50 nM), temozolomide (50 μM), and PLD2 inhibitor (10 μM) for 36 h, and caspase-3 activity was examined. e The cells were treated with SAHA, PLD2 inhibitor, or PA (50 μM) for 36 h. Apoptosis using annexin V staining was examined. f MDA-MB-231 cells were treated with the indicated drugs for 36 h, and caspase-3 activity and g expression of the indicated proteins were examined. The intensity of the indicated bands was normalized to the intensity of their respective α-tubulin bands and quantified against each other. Results are representative of at least four independent experiments and shown as the mean ± SEM. ** p < 0.001
Article Snippet: T247 and
Techniques: Inhibition, Transfection, Flow Cytometry, Labeling, Staining, Activity Assay, Expressing